CClinicalTrials.gg
Sign In
CompletedNCT06089200Updated Oct 18, 2023

TAP Block vs Spinal Orphine for Postoperative Caesarean Section Analgetics

A Phase 2 interventional study of Transversus Abdominal Plane Block and Spinal Morphine in Post Operative Pain, sponsored by Universitas Padjadjaran. Completed at 1 site in Indonesia. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-18.

Sponsored by Universitas Padjadjaran · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Feb 2023, registered Oct 2023).
Phase
Phase 2
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The goal of this randomized controlled trial is to compare the effect of TAP block vs spinal morphine for post caesarean section analgesics. The main questions it aims to answer are:

  • Which post op analgesic method works better for patients who underwent caesarean section
  • The number of additional opioid needed
02

Conditions studied

  • Post Operative Pain

Browse trials for

03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 44 is below the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Universitas Padjadjaran is the lead sponsor of 90 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Indicated for caesarean section as assessed by Obstetricians
  • ASA II
  • Consented to be included in the study

Exclusion criteria

Exclusion Criteria:

  • Allergy history
  • Spinal converted to general anesthesia
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
44 participants (actual)

Study arms

  • Experimental
    Transversus Abdominis Plane Block

    Twenty two subjects were given postoperative block administration in the transversus abdominis area on each side with ultrasonography (USG) guidance

    Procedure: Transversus Abdominal Plane Block

  • Active comparator
    Spinal Morphine

    Twenty two subjects were given additional morphine 100 µg intrathecally

    Procedure: Spinal Morphine

Interventions

  • ProcedureTransversus Abdominal Plane Block

    20 cc of bupivacaine 0.2% was given to the transversus abdominis plane

  • ProcedureSpinal Morphine

    100 µg was administered intrathecally preoperatively

06

What researchers measure

Primary outcomes

  1. Length of time the patient needed the first additional opioid analgesics

    Time frame: 24 hours post operative

  2. Total need for additional opioids

    Time frame: 24 hours post operative

07

Study locations

1 site
  • Hasan Sadikin General Hospital
    Bandung, Jawa Barat 40161, Indonesia
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06089200
Lead sponsor
Universitas Padjadjaran
Responsible party
Sponsor
First posted
Oct 18, 2023
Start date
Feb 23, 2023
Primary completion
Apr 28, 2023
Completion
Apr 28, 2023
Last update
Oct 18, 2023

Study contacts

Mohammad F Maulana, MD
principal investigator · Faculty of Medicine Universitas Padjadjaran Bandung
Suwarman, MD
study director · Faculty of Medicine Universitas Padjadjaran Bandung
Osmond M Pison, MD
study director · Faculty of Medicine Universitas Padjadjaran Bandung
Prapanca Nugraha, MD
study director · Faculty of Medicine Universitas Padjadjaran Bandung

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Pain, Postoperative→

Other studies from this sponsor

Universitas Padjadjaran

Start the discussion